Antitumor activities against breast cancers by an afucosylated anti‐HER2 monoclonal antibody H2Mab‐77‐mG2a‐f
Article in Cancer Science (November 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Targeting HER2 and FGFR-positive cancer cells with a bispecific cytotoxic conjugate combining anti-HER2 Affibody and FGF2
Article in International Journal of Biological Macromolecules (October 2023)
Antitumor Activities against Breast Cancers by an Afucosylated Anti-HER2 Monoclonal Antibody H2Mab-77-mG2a-f
Preprint in Preprints.org (July 2023)